Dizhe Pharmaceutical announced that Chairman and CEO Zhang Xiaolin, Board Secretary and Chief Financial Officer Lu Hongbin, and Wu Qingyi, Deputy General Manager and Chief Commercial Officer, intend to increase their company shares by 6.5 million yuan to 13 million yuan.
迪哲医药：董事、高级管理人员拟增持650万元-1300万元公司股份
Dizhe Pharmaceutical: Directors and senior management plan to increase their holdings of the company by 6.5 million yuan to 13 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.